Johnson & Johnson buy Wolfe Research
Start price
05.01.26
/
50%
€174.58
Target price
05.01.27
€205.22
Performance (%)
0.62%
Price
09.01.26
€175.66
Summary
This prediction is currently active. The BUY prediction by Wolfe_Research for Johnson & Johnson is nearly unchanged. This prediction currently runs until 05.01.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Johnson & Johnson | 0.62% |
| iShares Core DAX® | 3.002% |
| iShares Nasdaq 100 | 2.966% |
| iShares Nikkei 225® | 5.606% |
| iShares S&P 500 | 2.312% |
Comments by Wolfe_Research for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at Wolfe Research from $225.00 to $240.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Stopped prediction by Wolfe_Research for Johnson & Johnson
Johnson & Johnson
Start price
Target price
Perf. (%)
€143.80
15.11.24
15.11.24
€179.89
15.11.25
15.11.25
17.36%
16.11.25
16.11.25
